COMPANY
Gyre Therapeutics
Gyre Therapeutics is a commercial-stage biopharmaceutical company developing small-molecule therapeutics, with its most advanced programs in organ fibrosis and inflammatory disease. From company website Source · Oct 12, 2026
Timeline
- Raise Follow-on offering: $23M (total, as published), announced May 29, 2025. Source: company release on GlobeNewswire. source ↗
Funding
- Follow-on offering: $23M (total, as published), announced May 29, 2025. Source: company release on GlobeNewswire. source ↗